Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,148.42
(
0.00%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

jbog

Send PM Follow Ignore
Followers 64
Posts 11880
Boards Moderated 0
Alias Born 07/16/2006

jbog

Re: biotech_researcher post# 213272

Sunday, 08/27/2017 10:19:26 AM

Sunday, August 27, 2017 10:19:26 AM

Post# of 257580
The NEJM had the full report this morning on Canakinumab this morning.

Their editorial basically said that while treating inflammation looks very interesting to explore, at $100k to $200K per year, it isn't going to the masses.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today